Hypokalemia: A potentially life-threatening complication of tenofovir therapy
2017 ◽
Vol 5
◽
pp. 2050313X1774101
◽
Keyword(s):
Tenofovir is a nucleotide analog reverse transcriptase inhibitor approved for the treatment of HIV and hepatitis B infections. It is widely prescribed and an integral part of the recommended regimens for the treatment of HIV infection in antiretroviral-naive patients. Tenofovir is implicated in renal proximal tubular dysfunction, which can be associated with Fanconi syndrome and hypokalemia. When the hypokalemia is severe, it can lead to life-threatening complications. We describe the case of a 59-year-old woman who suffered a cardiac arrest secondary to severe hypokalemia from tenofovir use.
2015 ◽
Vol 39
(5)
◽
pp. e67-e69
◽
2018 ◽
Vol 29
(7)
◽
pp. 1849-1858
◽
2002 ◽
Vol 19
(Supplement 27)
◽
pp. 18-19
1977 ◽
Vol 62
(1)
◽
pp. 125-129
◽
2021 ◽